KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Thermo Fisher Scientific (TMO) Other Operating Expenses (2016 - 2025)

Historic Other Operating Expenses for Thermo Fisher Scientific (TMO) over the last 17 years, with Q3 2025 value amounting to $6.5 billion.

  • Thermo Fisher Scientific's Other Operating Expenses rose 429.03% to $6.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $25.7 billion, marking a year-over-year increase of 236.28%. This contributed to the annual value of $25.2 billion for FY2024, which is 224.79% down from last year.
  • Per Thermo Fisher Scientific's latest filing, its Other Operating Expenses stood at $6.5 billion for Q3 2025, which was up 429.03% from $6.4 billion recorded in Q2 2025.
  • In the past 5 years, Thermo Fisher Scientific's Other Operating Expenses ranged from a high of $6.8 billion in Q4 2022 and a low of $4.7 billion during Q4 2021
  • Moreover, its 5-year median value for Other Operating Expenses was $6.4 billion (2022), whereas its average is $6.1 billion.
  • In the last 5 years, Thermo Fisher Scientific's Other Operating Expenses surged by 3624.71% in 2022 and then crashed by 656.01% in 2024.
  • Over the past 5 years, Thermo Fisher Scientific's Other Operating Expenses (Quarter) stood at $5.4 billion in 2021, then grew by 25.62% to $6.8 billion in 2022, then fell by 5.13% to $6.5 billion in 2023, then rose by 1.25% to $6.6 billion in 2024, then dropped by 0.53% to $6.5 billion in 2025.
  • Its Other Operating Expenses stands at $6.5 billion for Q3 2025, versus $6.4 billion for Q2 2025 and $6.1 billion for Q1 2025.